Common Multiple Sclerosis Drugs Taken Together Do Not Reduce Relapse Risk



science-daily-logoA recent clinical trial found that interferon²-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.

To read the full article, click here.